← Leaderboards
Kathryn J. Swoboda
University Of Utah
$8,521,069
Attributed
$8,968,985
Total exposure
15
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2005–19$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$8,968,985 · 15
By mechanism
R01$5,800,052 · 2
M01$1,809,725 · 11
U10$895,833 · 1
R21$463,375 · 1
Top collaborators
- A Gordon Smith3 shared
Most similar at University Of Utah
Same institution · by research overlap
- Mary C. Beckerle$16,693,203
- Trudy Gale Oliver$9,454,558
- Geraldine P Mineau$6,862,223
- Mark B Bromberg$338,221
- Nicola J Camp$10,676,027
Others in their field
Top investigators on “Research Personnel”
- David Heimbrook · Leidos Biomedical Research, Inc.$701,463,488
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$557,978,666
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David R. Weir · University Of Michigan At Ann Arbor$364,053,504
- Judith S. Currier · University Of California Los Angeles$284,675,012
Research focus
Research PersonnelChildMotor NeuronsMotorAffectSpinal Muscular AtrophyCohortSmn2 GeneInfantDisease ProgressionOutcome MeasurePilot ProjectsFamilyFunctional DisorderClinical ResearchEvaluationLaboratoriesPhenotypeDatabasesDenervationMuscleChildhoodMortality Vital StatisticsIncidence
Grant awards (29)
Neural and non-neural contributions to phenotype in human SMA type 1$252,750
R21 · FY2019 · NS · contact PI
Neural and non-neural contributions to phenotype in human SMA type 1$210,625
R21 · FY2018 · NS · contact PI
Newborn screening for identification & prospective followup of infants with SMA$862,570
R01 · FY2015 · HD · contact PI
Newborn screening for identification & prospective followup of infants with SMA$844,277
R01 · FY2014 · HD · contact PI
Newborn screening for identification & prospective followup of infants with SMA$829,882
R01 · FY2013 · HD · contact PI
The Utah Regional Network for Excellence in Neuroscience Clinical Trials$298,000
U10 · FY2013 · NS
Newborn screening for identification & prospective followup of infants with SMA$880,535
R01 · FY2012 · HD · contact PI
The Utah Regional Network for Excellence in Neuroscience Clinical Trials$298,833
U10 · FY2012 · NS
Newborn screening for identification & prospective followup of infants with SMA$899,997
R01 · FY2011 · HD · contact PI
The Utah Regional Network for Excellence in Neuroscience Clinical Trials$299,000
U10 · FY2011 · NS
Therapeutic Opportunities in Spinal Muscular Atrophy$256,506
R01 · FY2011 · HD · contact PI
Therapeutic Opportunities in Spinal Muscular Atrophy$267,193
R01 · FY2010 · HD · contact PI
Therapeutic Opportunities in Spinal Muscular Atrophy$143,908
R01 · FY2010 · HD · contact PI
Therapeutic Opportunities in Spinal Muscular Atrophy$269,892
R01 · FY2009 · HD · contact PI
Therapeutic Opportunities in Spinal Muscular Atrophy$269,892
R01 · FY2008 · HD · contact PI
CLINICAL TRIAL: VALPROIC ACID AND CARNITINE IN PATIENTS WITH SPINAL MUSCULAR ATR$46,821
M01 · FY2008 · RR · contact PI
CLINICAL AND GENETIC ANALYSIS OF SPINAL MUSCULAR ATROPHY$31,639
M01 · FY2008 · RR · contact PI
CLINICAL AND MOLECULAR ANALYSIS OF NEUROMUSCULAR DISEASE$344
M01 · FY2008 · RR · contact PI
VALPROIC ACID AND CARNITINE IN PATIENTS WITH SPINAL MUSCULAR ATROPHY$298,263
M01 · FY2007 · RR · contact PI
Therapeutic Opportunities in Spinal Muscular Atrophy$275,400
R01 · FY2007 · HD · contact PI
CLINICAL AND GENETIC ANALYSIS OF SPINAL MUSCULAR ATROPHY$201,528
M01 · FY2007 · RR · contact PI
CLINICAL AND MOLECULAR ANALYSIS OF NEUROMUSCULAR DISEASE$2,190
M01 · FY2007 · RR · contact PI
CLINICAL AND MOLECULAR STUDIES IN SPINAL MUSCULAR ATROPHY$281,632
M01 · FY2006 · RR · contact PI
VALPROIC ACID AND CARNITINE IN PATIENTS WITH SPINAL MUSCULAR ATROPHY$193,935
M01 · FY2006 · RR · contact PI
GENETIC CHARACTERIZATION OF EPISODIC NEUROLOGIC DYSFUNCTION$1,388
M01 · FY2006 · RR · contact PI
CLINICAL AND MOLECULAR STUDIES IN SPINAL MUSCULAR ATROPHY$423,255
M01 · FY2005 · RR
GENETIC CHARACTERIZATION OF EPISODIC NEUROLOGIC DYSFUNCTION$5,034
M01 · FY2005 · RR
Clinical and molecular studies in spinal muscular atrophy$317,143
M01 · FY2004 · RR
Genetic characterization of episodic neurologic dysfunction$6,553
M01 · FY2004 · RR